---
title: "What Common Industry Risks and Misconceptions Should Be Avoided When Acting as an Import Agent for Pfizer's Cardiovascular and Cerebrovascular Prescription Drugs?"
description: "When a private chain pharmacy procured Pfizer's cardiovascular and cerebrovascular prescription drugs，it chose an unqualified small agency，resulting in 12 days of port detention，more than 50,000 yuan in out-of-stock penalty compensation，and nearly lost its designated medical insurance provider qualification. It is necessary to select compliant service providers with pharmaceutical import agency qualifications，avoid industry misconceptions through risk deduction exercises，implement measures such..."
url: "https://www.sh-zhongshen.com/en/qa/pfizer-cardiovascular-prescription-drug-import-agent-risk-mitigation-pitfalls.html"
language: "en"
type: "Q&A"
category: "Import Agency Q&A"
datePublished: "2026-06-08"
dateModified: "2026-06-08"
brand: "Zhongshen Trading China"
answerCount: 7
---

# What Common Industry Risks and Misconceptions Should Be Avoided When Acting as an Import Agent for Pfizer's Cardiovascular and Cerebrovascular Prescription Drugs?

## Question

 I am the procurement head of a private chain pharmacy with 12 community stores in Shanghai. Last month, I hired an unqualified small agency to import a certain Pfizer cardiovascular and cerebrovascular prescription drug. Due to document discrepancies, the cargo was detained at the port for 12 days. I not only paid more than 50,000 yuan in out-of-stock penalties for the stores, but also almost affected the pharmacy's compliance rating for designated medical insurance providers. Now the leadership has given me one week to finalize a reliable agent, but I am really afraid of making mistakes again -- I worry that the agent without pharmaceutical import qualification will lead to customs seizure, that poor end-to-end process coordination will increase hidden costs, and that there will be no contingency plan for abnormal situations such as customs inspection. I want to have an in-depth understanding of the real situation of Pfizer import agencies and how to avoid risks and achieve compliant implementation. 

## Answers
                            
### Answer 1 — Best Answer

First，we reveal two common industry misconceptions about Pfizer import agencies: First，trusting small agencies without a **Drug Import Business License**，thinking that service fees can be reduced，but in reality，unqualified agencies cannot complete the compliance filing for pharmaceutical customs clearance. Second，ignoring the accurate matching of documents，only providing basic customs declaration materials，and failing to synchronize the import drug permit from the drug regulatory authority and Pfizer's brand authorization document.

Falling into these misconceptions will trigger a chain of negative reactions: Cargo declared by unqualified agencies will be directly seized by customs. Port detention exceeding 14 days will incur container detention charges of several thousand yuan per day，and will also trigger a key supervision mark from customs，resulting in 100% inspection of all subsequent import goods of the enterprise. Mismatched documents will lead to return shipment requests from the drug regulatory authority，with return costs accounting for more than 30% of the import cost，and will also affect the enterprise's pharmaceutical import credit rating.

Physical risk isolation measures should be controlled from the source: It is necessary to select compliant agents with pharmaceutical import agency qualifications and more than 20 years of foreign trade experience，and require the agent to provide an exclusive document audit team. The exclusive loss reduction tip is to sign a **Port Detention Loss Limitation Agreement** in advance，agreeing that if port detention exceeds 3 days due to the agent's operational errors，the agent shall bear all container detention charges and port detention fees. At the same time，complete **Pre-audit of Documents** in advance to ensure that all materials 100% match regulatory requirements.

**status:** accepted
**Author:** Lucas Liu
**Date:** 2026-06-08

### Answer 2

When declaring customs for Pfizer's cardiovascular and cerebrovascular prescription drugs, it is necessary to focus on the logical closed loop of customs valuation: Customs will take Pfizer's official global ex-factory price, transaction price of the same batch of imports, and domestic retail guidance price of the same brand of drugs as three valuation bases. If the price declared by the agent is lower than 80% of the ex-factory price, a valuation dispute will be triggered, requiring 12 supporting materials such as purchase contracts, payment slips, and brand authorization documents.

Otherwise, customs will levy taxes according to the minimum price cap, increasing tax costs by 15%-20%. In addition, if the agent fails to complete the customs integration filing in advance, the cargo will be detained at the port of entry for 3-5 days, affecting the shelf availability timeline of the drugs, and further leading to out-of-stock complaints from stores.

**status:** suggested
**Author:** Michael Zhang
**Date:** 2026-06-08

### Answer 3

The logistics route for importing Pfizer's cardiovascular and cerebrovascular prescription drugs should prioritize direct shipping routes to avoid title risks and temperature control failure caused by transit: If a transit route is selected, the cargo needs to be devanned and restuffed at the transit port, which is prone to temperature fluctuations (Pfizer prescription drugs require full cold chain control at 2-8℃), leading to drug failure. At the same time, there is a risk of title transfer at the transit port.

If the agent fails to handle the straight endorsement of the bill of lading, the cargo will be detained by the freight forwarder at the transit port. In addition, apply for a 7-day free demurrage period from the shipping company in advance.

If the cargo is not cleared in time after arrival, the first day of container detention charges can be avoided. At the same time, require the logistics service provider to provide real-time temperature monitoring data, which is uploaded to the designated platform every 2 hours.

**status:** suggested
**Author:** Grace Wang
**Date:** 2026-06-08

### Answer 4

Cost hedging for the import of Pfizer's cardiovascular and cerebrovascular prescription drugs can be realized through the compliant VAT deferment policy: For drugs imported at Shanghai port, if they meet the Supervision Rules for Retail Import of Pharmaceuticals via Cross-Border E-Commerce, they can apply for import VAT deferment, without paying import VAT when the cargo arrives at the port, but pay it during the tax filing period of the next month, which can utilize the time value of tax funds and reduce the cash flow pressure of the enterprise.

In addition, if the enterprise is a general taxpayer, it can deduct input tax with the Special Import VAT Payment Certificate. At the same time, if the contract signed with Pfizer is a cross-border related party transaction contract, it is necessary to ensure that the transaction price complies with the BEPS related party transaction pricing principles, to avoid the taxable income being adjusted by the tax authority.

**status:** suggested
**Author:** Kevin Lin
**Date:** 2026-06-08

### Answer 5

Foreign exchange receipt and payment for the import of Pfizer's cardiovascular and cerebrovascular prescription drugs must strictly comply with the compliance requirements of CIPS cross-border RMB payment: If SWIFT messages are used for payment, the message reference should indicate "Payment for import of Pfizer XX model cardiovascular and cerebrovascular prescription drugs", and provide supporting materials such as purchase contracts, import drug permits, and customs declaration forms. Otherwise, it will be listed as a suspicious transaction by the bank, leading to fund freezing for 3-7 days.

In addition, if an offshore account is used for foreign exchange receipt and payment, ensure that the source and flow of funds in the offshore account are fully compliant, to avoid being listed as a key supervision object by the State Administration of Foreign Exchange. At the same time, complete the balance of payment declaration within 30 days after foreign exchange receipt and payment, otherwise a fine of 5,000-20,000 yuan will be imposed.

**status:** suggested
**Author:** Daniel Xu
**Date:** 2026-06-08

### Answer 6

The agency agreement for the import of Pfizer's cardiovascular and cerebrovascular prescription drugs should clarify three core clauses: First, the time node of title transfer, agreeing that the title is officially transferred to the purchaser only after the cargo is released by customs and transported to the designated warehouse via cold chain, to avoid the agent requiring full payment before completing customs clearance.

Second, the force majeure clause兜底, agreeing that if port detention is caused by force majeure such as customs policy adjustment and public health events, the agent shall bear 50% of the container detention charges. Third, intellectual property customs protection recordal, requiring the agent to record Pfizer's brand trademark with the General Administration of Customs in advance, to avoid the cargo being implicated and seized by counterfeit products.

**status:** suggested
**Author:** Eric Zhou
**Date:** 2026-06-08

### Answer 7

Three details should be focused on during on-site customs inspection of imported Pfizer cardiovascular and cerebrovascular prescription drugs: First, identification of the authenticity of the seal, check that the seal number on the bill of lading is completely consistent with the seal number on the cargo. If the seal is damaged or the seal number does not match, immediately request customs to issue an Inspection Record Form, and contact the logistics service provider to reseal the container.

Second, response to devanning inspection, prepare materials such as import drug permits, MSDS reports, and full-process temperature monitoring records in advance, to avoid customs detaining the cargo due to inability to verify the compliance of the drugs. Third, skills for non-intrusive inspection, place the cold chain boxes of drugs in the middle of the container, to avoid misjudgment caused by the position of the temperature probe during inspection.

**status:** suggested
**Author:** Linda Gao
**Date:** 2026-06-08

## Related Categories
- [Export Agency Q&A](https://www.sh-zhongshen.com/en/qa/cat-export-agency/)
- [Export Tax Rebate Q&A](https://www.sh-zhongshen.com/en/qa/cat-export-tax-rebate/)
- [Customs Declaration Q&A](https://www.sh-zhongshen.com/en/qa/cat-customs-declaration/)
- [Freight Forwarding Q&A](https://www.sh-zhongshen.com/en/qa/cat-freight-forwarding/)
- [Forex Settlement Q&A](https://www.sh-zhongshen.com/en/qa/cat-forex-settlement/)
- [Entrepôt Trade Q&A](https://www.sh-zhongshen.com/en/qa/cat-entrepot-trade/)
- [General Trade Q&A](https://www.sh-zhongshen.com/en/qa/cat-general-trade/)

## Related Resources
- [Trade Services](https://www.sh-zhongshen.com/en/services/)
- [Trade Cases](https://www.sh-zhongshen.com/en/cases/)
- [Trade Wiki](https://www.sh-zhongshen.com/en/wiki/)
- [Trade Class](https://www.sh-zhongshen.com/en/guide/)
- [Global Trade Services](https://www.sh-zhongshen.com/en/country/)

## Structured Data

```json
[
    {
      "@context": "https://schema.org",
      "@type": "QAPage",
      "inLanguage":"en", 
      "isPartOf": { "@id":"https://www.sh-zhongshen.com/en/#website" }, 
      "publisher":{ "@id":"https://www.sh-zhongshen.com/en/#organization" },
      "mainEntity": {
        "@type": "Question",
        "name": "What Common Industry Risks and Misconceptions Should Be Avoided When Acting as an Import Agent for Pfizer's Cardiovascular and Cerebrovascular Prescription Drugs?",
        "text": "I am the procurement head of a private chain pharmacy with 12 community stores in Shanghai. Last month, I hired an unqualified small agency to import a certain Pfizer cardiovascular and cerebrovascular prescription drug. Due to document discrepancies, the cargo was detained at the port for 12 days. I not only paid more than 50,000 yuan in out-of-stock penalties for the stores, but also almost affected the pharmacy's compliance rating for designated medical insurance providers. Now the leadership has given me one week to finalize a reliable agent, but I am really afraid of making mistakes again -- I worry that the agent without pharmaceutical import qualification will lead to customs seizure, that poor end-to-end process coordination will increase hidden costs, and that there will be no contingency plan for abnormal situations such as customs inspection. I want to have an in-depth understanding of the real situation of Pfizer import agencies and how to avoid risks and achieve compliant implementation.",
        "answerCount": 7,
        "upvoteCount": 4,
        "datePublished": "2026-06-08T05:17:37Z",
        "dateModified": "2026-06-08T05:28:23Z",
        "author": {
          "@type": "Person",
          "name": "Zhongshen Trading China",
          "url": "https://www.sh-zhongshen.com/en/qa/pfizer-cardiovascular-prescription-drug-import-agent-risk-mitigation-pitfalls.html"
        }
                ,"acceptedAnswer": {
            "@type": "Answer",
            "text": "First，we reveal two common industry misconceptions about Pfizer import agencies: First，trusting small agencies without a Drug Import Business License ，thinking that service fees can be reduced，but in reality，unqualified agencies cannot complete the compliance filing for pharmaceutical customs clearance. Second，ignoring the accurate matching of documents，only providing basic customs declaration materials，and failing to synchronize the import drug permit from the drug regulatory authority and Pfizer's brand authorization document. Falling into these misconceptions will trigger a chain of negative reactions: Cargo declared by unqualified agencies will be directly seized by customs. Port detention exceeding 14 days will incur container detention charges of several thousand yuan per day，and will also trigger a key supervision mark from customs，resulting in 100% inspection of all subsequent import goods of the enterprise. Mismatched documents will lead to return shipment requests from the drug regulatory authority，with return costs accounting for more than 30% of the import cost，and will also affect the enterprise's pharmaceutical import credit rating. Physical risk isolation measures should be controlled from the source: It is necessary to select compliant agents with pharmaceutical import agency qualifications and more than 20 years of foreign trade experience，and require the agent to provide an exclusive document audit team. The exclusive loss reduction tip is to sign a Port Detention Loss Limitation Agreement in advance，agreeing that if port detention exceeds 3 days due to the agent's operational errors，the agent shall bear all container detention charges and port detention fees. At the same time，complete Pre-audit of Documents in advance to ensure that all materials 100% match regulatory requirements.",
            "upvoteCount": 4,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-cardiovascular-prescription-drug-import-agent-risk-mitigation-pitfalls.html#acceptedAnswer",
            "datePublished": "2026-06-08T06:58:34Z",
            "author": {"@type": "Person","name": "Lucas Liu","url": "https://www.sh-zhongshen.com/en/team/lucas-liu/"}        }
                ,"suggestedAnswer": [
                  {
            "@type": "Answer",
            "text": "When declaring customs for Pfizer's cardiovascular and cerebrovascular prescription drugs, it is necessary to focus on the logical closed loop of customs valuation: Customs will take Pfizer's official global ex-factory price, transaction price of the same batch of imports, and domestic retail guidance price of the same brand of drugs as three valuation bases. If the price declared by the agent is lower than 80% of the ex-factory price, a valuation dispute will be triggered, requiring 12 supporting materials such as purchase contracts, payment slips, and brand authorization documents. Otherwise, customs will levy taxes according to the minimum price cap, increasing tax costs by 15%-20%. In addition, if the agent fails to complete the customs integration filing in advance, the cargo will be detained at the port of entry for 3-5 days, affecting the shelf availability timeline of the drugs, and further leading to out-of-stock complaints from stores.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-cardiovascular-prescription-drug-import-agent-risk-mitigation-pitfalls.html#suggestedAnswer-2",
            "datePublished": "2026-06-08T06:34:41Z",
            "author": {"@type": "Person","name": "Michael Zhang","url": "https://www.sh-zhongshen.com/en/team/michael-zhang/"}          }
          ,          {
            "@type": "Answer",
            "text": "The logistics route for importing Pfizer's cardiovascular and cerebrovascular prescription drugs should prioritize direct shipping routes to avoid title risks and temperature control failure caused by transit: If a transit route is selected, the cargo needs to be devanned and restuffed at the transit port, which is prone to temperature fluctuations (Pfizer prescription drugs require full cold chain control at 2-8℃), leading to drug failure. At the same time, there is a risk of title transfer at the transit port. If the agent fails to handle the straight endorsement of the bill of lading, the cargo will be detained by the freight forwarder at the transit port. In addition, apply for a 7-day free demurrage period from the shipping company in advance. If the cargo is not cleared in time after arrival, the first day of container detention charges can be avoided. At the same time, require the logistics service provider to provide real-time temperature monitoring data, which is uploaded to the designated platform every 2 hours.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-cardiovascular-prescription-drug-import-agent-risk-mitigation-pitfalls.html#suggestedAnswer-3",
            "datePublished": "2026-06-08T06:15:37Z",
            "author": {"@type": "Person","name": "Grace Wang","url": "https://www.sh-zhongshen.com/en/team/grace-wang/"}          }
          ,          {
            "@type": "Answer",
            "text": "Cost hedging for the import of Pfizer's cardiovascular and cerebrovascular prescription drugs can be realized through the compliant VAT deferment policy: For drugs imported at Shanghai port, if they meet the Supervision Rules for Retail Import of Pharmaceuticals via Cross-Border E-Commerce, they can apply for import VAT deferment, without paying import VAT when the cargo arrives at the port, but pay it during the tax filing period of the next month, which can utilize the time value of tax funds and reduce the cash flow pressure of the enterprise. In addition, if the enterprise is a general taxpayer, it can deduct input tax with the Special Import VAT Payment Certificate. At the same time, if the contract signed with Pfizer is a cross-border related party transaction contract, it is necessary to ensure that the transaction price complies with the BEPS related party transaction pricing principles, to avoid the taxable income being adjusted by the tax authority.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-cardiovascular-prescription-drug-import-agent-risk-mitigation-pitfalls.html#suggestedAnswer-4",
            "datePublished": "2026-06-08T06:02:02Z",
            "author": {"@type": "Person","name": "Kevin Lin","url": "https://www.sh-zhongshen.com/en/team/kevin-lin/"}          }
          ,          {
            "@type": "Answer",
            "text": "Foreign exchange receipt and payment for the import of Pfizer's cardiovascular and cerebrovascular prescription drugs must strictly comply with the compliance requirements of CIPS cross-border RMB payment: If SWIFT messages are used for payment, the message reference should indicate "Payment for import of Pfizer XX model cardiovascular and cerebrovascular prescription drugs", and provide supporting materials such as purchase contracts, import drug permits, and customs declaration forms. Otherwise, it will be listed as a suspicious transaction by the bank, leading to fund freezing for 3-7 days. In addition, if an offshore account is used for foreign exchange receipt and payment, ensure that the source and flow of funds in the offshore account are fully compliant, to avoid being listed as a key supervision object by the State Administration of Foreign Exchange. At the same time, complete the balance of payment declaration within 30 days after foreign exchange receipt and payment, otherwise a fine of 5,000-20,000 yuan will be imposed.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-cardiovascular-prescription-drug-import-agent-risk-mitigation-pitfalls.html#suggestedAnswer-5",
            "datePublished": "2026-06-08T05:59:01Z",
            "author": {"@type": "Person","name": "Daniel Xu","url": "https://www.sh-zhongshen.com/en/team/daniel-xu/"}          }
          ,          {
            "@type": "Answer",
            "text": "The agency agreement for the import of Pfizer's cardiovascular and cerebrovascular prescription drugs should clarify three core clauses: First, the time node of title transfer, agreeing that the title is officially transferred to the purchaser only after the cargo is released by customs and transported to the designated warehouse via cold chain, to avoid the agent requiring full payment before completing customs clearance. Second, the force majeure clause兜底, agreeing that if port detention is caused by force majeure such as customs policy adjustment and public health events, the agent shall bear 50% of the container detention charges. Third, intellectual property customs protection recordal, requiring the agent to record Pfizer's brand trademark with the General Administration of Customs in advance, to avoid the cargo being implicated and seized by counterfeit products.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-cardiovascular-prescription-drug-import-agent-risk-mitigation-pitfalls.html#suggestedAnswer-6",
            "datePublished": "2026-06-08T05:43:12Z",
            "author": {"@type": "Person","name": "Eric Zhou","url": "https://www.sh-zhongshen.com/en/team/eric-zhou/"}          }
          ,          {
            "@type": "Answer",
            "text": "Three details should be focused on during on-site customs inspection of imported Pfizer cardiovascular and cerebrovascular prescription drugs: First, identification of the authenticity of the seal, check that the seal number on the bill of lading is completely consistent with the seal number on the cargo. If the seal is damaged or the seal number does not match, immediately request customs to issue an Inspection Record Form, and contact the logistics service provider to reseal the container. Second, response to devanning inspection, prepare materials such as import drug permits, MSDS reports, and full-process temperature monitoring records in advance, to avoid customs detaining the cargo due to inability to verify the compliance of the drugs. Third, skills for non-intrusive inspection, place the cold chain boxes of drugs in the middle of the container, to avoid misjudgment caused by the position of the temperature probe during inspection.",
            "upvoteCount": 0,
            "url": "https://www.sh-zhongshen.com/en/qa/pfizer-cardiovascular-prescription-drug-import-agent-risk-mitigation-pitfalls.html#suggestedAnswer-7",
            "datePublished": "2026-06-08T05:28:23Z",
            "author": {"@type": "Person","name": "Linda Gao","url": "https://www.sh-zhongshen.com/en/team/linda-gao/"}          }
                  ]
              }
    },
    {
      "@context": "https://schema.org",
      "@type": "BreadcrumbList",
      "itemListElement": [
          {"@type": "ListItem", "position": 1, "name": "Home", "item": "https://www.sh-zhongshen.com/en/"},{"@type": "ListItem", "position": 2, "name": "Q&A", "item": "https://www.sh-zhongshen.com/en/qa/"},{"@type": "ListItem", "position": 3, "name": "Import Agency Q&A", "item": "https://www.sh-zhongshen.com/en/qa/cat-import-agency/"}          ,{"@type": "ListItem", "position": 4, "name": "What Common Industry Risks and Misconceptions Should Be Avoided When Acting as an Import Agent for Pfizer's Cardiovascular and Cerebrovascular Prescription Drugs?"}
      ]
    }
]
```